Brainstorm Announces Grant of a New Japanese Patent for NurOwn®

PRNewswire/ — Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, …
( read original story …)